patellofemoral pain syndrome. Other soft tissue disorders related to use, overuse and pressure
Conditions
Interventions
Intervention 1: Intervention group 1: ischemic compression: Treatment in this group involves applying tolerably painful, persistent manual pressure (usually with the thumb) against the tissue barrier
Rehabilitation
Intervention group 1: ischemic compression: Treatment in this group involves applying tolerably painful, persistent manual pressure (usually with the thumb) against the tissue barrier of the MTrP. Th
Intervention group 2: dry needling: the needle was inserted perpendicularly through the skin over the MTrP area, using the fast-in and fast-out technique and moved forward until a local twitch respon
Sponsors
investigator
Eligibility
Sex/Gender
All
Age
20 Years to 30 Years
Inclusion criteria
Inclusion criteria: The inclusion criteria are: 1) reported pain of more than 6 weeks’ duration in at least two of the following situations: patellar compression, squatting, prolonged sitting, walking, stair climbing, isometric quadriceps contraction (Crossley K et al 2002; Whittingham M et al 2004; Iverson et al 2008); 2) reported pain in one of the following tests: vastus medialis coordination test, patellar apprehension test, eccentric step test (Nijs J et al 2006); 3) presence of at least one MTrP in the VMO of the symptomatic knee (pressure applied to the VMO produced pain); 4) Kujala questionnaire score between 40 and 70, and visual analog scale (VAS) score greater than 40. Volunteers will exclud if they had a history of any of the following: ligamentous insufficiency of the knee, meniscus damage, patellar subluxation or dislocation, nerve root compression, spine or lower extremity surgery, any systemic, orthopedic or neurological disorder, or current physical therapy (Iverson CA et al. 2008; Hains G and Hains F 2010; Grindstaff TL et al 2012).
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain. Timepoint: before treatment, 1 week after treatment, 1 month after treatment, 3 months after treatment. Method of measurement: NPRS.;PPT. Timepoint: before treatment, 1 week after treatment, 1 month after treatment, 3 months after treatment. Method of measurement: digital algometry.;Functional status. Timepoint: before treatment, 1 week after treatment, 1 month after treatment, 3 months after treatment. Method of measurement: kujala questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactShabnam Behrangrad
Mazandaran University of Medical Sciences
Outcome results
None listed